Maloney co-sponsored the 2009 reintroduction of the Fair Copyright in Research Works Act (, originally introduced as in 2008) as well as the Research Works Act () introduced in 2011. Both bills aim to reverse the NIH's Public Access Policy, which mandates open access to NIH-funded research. The Association of American Publishers-backed Research Works Act was criticized by some scientists. In a "New York Times" op-ed, Michael Eisen described how the bill would force the public to pay $15–$30 per paper to read the results of research they had already paid for as taxpayers. (Such results must now be published in Pubmed Central (PMC) after an embargo period of up to 12 months: this embargo period was imposed to minimize financial harm to publishers who were concerned that their readership would diminish if the results appeared concurrently in PMC, though authors of the paper are required to submit their papers to PMC as soon as their paper gets accepted for publication by a peer-review journal.) Some have suggested that Maloney supports the measure because she is the recipient of campaign contributions from Elsevier, the largest scholarly publishing company. On February 27, 2012, following a boycott of the organization, In a letter to constituents, Maloney noted that "it is important to be mindful of the impact of various industries on job creation and retention. New York State is home to more than 300 publishers that employ more than 12,000 New Yorkers, many of whom live in or around New York City in my district. New York City scientific publishers represent a significant subset of the total, and more than 20 are located in Manhattan, publishing thousands of scientific journals and employing thousands of New Yorkers." Elsevier withdrew their support for the legislation.